COMMUNIQUÉS West-GlobeNewswire

Vera Therapeutics Announces Expanded Atacicept Development Program In Multiple Autoimmune Kidney Diseases

02/10/2024 - 12:30

PIONEER study expands the investigation of atacicept into a broad definition of IgA nephropathy and into multiple autoimmune glomerular diseases, supported by the disease-modifying potential of BAFF/APRIL dual [...]

Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer

02/10/2024 - 12:30

Glioblastoma study achieves milestone with successful dose escalation, setting stage for Phase 2 MILAN and NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a pioneer in immuno-oncology and a [...]

The Ensign Group Acquires Healthcare Campus in Nebraska

02/10/2024 - 12:00

SAN JUAN CAPISTRANO, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]

Oculis Announces Appointment of Daniel S. Char as Chief Legal Officer

02/10/2024 - 10:00

ZUG, Switzerland, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Mr. Char brings extensive experience in leading legal, compliance and corporate governance functions in successful biotech and medical device companies The appointment [...]

Oculis Announces Appointment of Daniel S. Char as Chief Legal Officer

02/10/2024 - 10:00

Mr. Char brings extensive experience in leading legal, compliance and corporate governance functions in successful biotech and medical device companies The appointment further expands Oculis’ leadership team as the [...]

Nexstim Receives NBS System 5 Order from European Customer

02/10/2024 - 08:00

Press release, Helsinki, 2 October 2024 at 9 AM (EEST) Nexstim Receives NBS System 5 Order from European Customer Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS System 5 from an [...]

EssilorLuxottica Completes Acquisition of Supreme® from VF Corporation

02/10/2024 - 07:00

EssilorLuxottica Completes Acquisition of Supreme ® from VF Corporation Paris, France and Denver, Colorado (USA) (October 2, 2024 – 7am CEST) – EssilorLuxottica, a global leader in the optical industry, announced that [...]

EssilorLuxottica finalise l'acquisition de Supreme® auprès de VF Corporation

02/10/2024 - 07:00

EssilorLuxottica finalise l'acquisition de Supreme ® auprès de VF Corporation Paris, France et Denver, États-Unis (2 octobre 2024 – 7h00)– EssilorLuxottica, leader mondial de l'industrie optique, a annoncé avoir [...]

EssilorLuxottica Completes Acquisition of a Majority Stake in Heidelberg Engineering

02/10/2024 - 07:00

EssilorLuxottica Completes Acquisition of a Majority Stake in Heidelberg Engineering Paris, France and Heidelberg, Germany (October 2, 2024 – 7am CEST) – EssilorLuxottica, a global leader in the optical industry, [...]

EssilorLuxottica finalise l’acquisition d'une participation majoritaire dans Heidelberg

02/10/2024 - 07:00

EssilorLuxottica finalise l’acquisition d'une participation majoritaire dans Heidelberg Paris, France et Heidelberg, Allemagne (2 octobre 2024 – 7h00) – EssilorLuxottica, leader mondial de l'industrie optique, a annoncé [...]

CARBIOS announces half-year 2024 financial results and presents its industrial and commercial progress

02/10/2024 - 06:45

Construction progress of world’s first PET enzymatic biorecycling plant in France: in line with production targets in 2026 Commercial development: several Letters of Intent signed in view of licensing agreements [...]

CARBIOS annonce ses Résultats semestriels 2024 et présente ses avancées industrielles et commerciales

02/10/2024 - 06:45

Avancée de la construction, en France, de la première usine au monde de biorecyclage enzymatique du PET : progression des travaux conforme aux objectifs de production dès 2026 Développement commercial : signature de [...]

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02/10/2024 - 00:25

ORLANDO, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted two newly-hired [...]

COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director

01/10/2024 - 23:30

TORONTO, ONTARIO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified [...]

Vision Sensing Acquisition Corp. Announces Intention to Extend the Period to Consummate Its Initial Business Combination to November 3, 2024

01/10/2024 - 22:40

NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “ Company ”) a special purpose acquisition company, announced today that it has notified Continental Stock [...]

Pliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical Affairs

01/10/2024 - 22:35

Former Bristol Myers Squibb Global Medical Affairs Lead brings over 25 years of experience to Pliant SOUTH SAN FRANCISCO, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage [...]

BioAge Labs Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of the Concurrent Private Placement

01/10/2024 - 22:30

RICHMOND, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (“BioAge”) (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as [...]

Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference

01/10/2024 - 22:05

SAN DIEGO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on a variety of chronic [...]

BrightSpring Health Services, Inc. to Announce Third Quarter 2024 Financial Results on November 1, 2024

01/10/2024 - 22:05

LOUISVILLE, Ky., Oct. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its third quarter 2024 financial results on [...]